Clare Arnott's Publications
About Clare Arnott's Publications
Co-Director, Cardiovascular Program- Co-Director, Global Chronic & Complex Diseases
- BMed Sci,
- MBBS (Hons),
- PhD,
- FRACP,
- FESC,
- CF
-
Radial First in Primary Percutaneous Coronary Intervention-Ensuring At-Risk Groups Aren’t Left Behind
Heart, Lung and Circulation Date published: -
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial
Diabetes & Metabolism Date published: -
Mechanisms of action of the sodium-glucose cotransporter-2 ( SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial
Diabetes, Obesity and Metabolism Date published: -
Optimising mothers’ health behaviour after hypertensive disorders of pregnancy: a qualitative study of a postnatal intervention
BMC Public Health Date published: -
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis
Diabetes, Obesity and Metabolism Date published: -
862-P: Interleukin-6 and Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Post Hoc Analysis of CANVAS Trial
Diabetes Date published: -
Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial
Journal of Diabetes Research Date published: -
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
Circulation Date published: -
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial
Diabetes, Obesity and Metabolism Date published: -
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial
Clinical Journal of the American Society of Nephrology Date published: -
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease
Clinical Journal of the American Society of Nephrology Date published: -
Colchicine in Cardiovascular Disease: In-Depth Review
Circulation Date published: -
Sex disaggregated analysis of risk factors for adverse outcomes in hypertrophic cardiomyopathy
Date published: -
Interleukin-6 and cardiovascular outcome in patients with type 2 diabetes: new insights from CANVAS
Diabetologia Date published: -
Sex Disaggregated Analysis of Risk Factors for Adverse Outcomes in Hypertrophic Cardiomyopathy
Heart, Lung and Circulation Date published: -
Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm
Trials Date published: